Skip to main content

Table 2 Overall survival in AFD, TMB and Kaplan–Meier estimates in the training group

From: Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)

Variable

Low-value group (n = 40)

High-value group (n = 14)

AFD

 Deaths—no. (%)a

4

6

 Data censoredb

36

8

 Median overall survival—mo (95% CI)

NE

NE

 The overall survival (95% CI) by Kaplan–Meier estimation

 12 mo

95% (88.5–100)

78.6% (59.8–100)

 31 mo

89.7% (80.6–99.8)

64.3% (43.5–95)

 35 mo

NA

56.2% (35.2–90)

TMB

 Deaths—no. (%)a

5

5

 Data censoredb

35

9

 Median overall survival—mo (95% CI)

NE

NE

 The overall survival (95% CI) by Kaplan–Meier estimation

 13 mo

92.5(84.7–100)

78.6 (59.8–100)

 31 mo

89.9 (80.9–99.8)

62.5 (41–95.3)

 35 mo

87.1 (77.2–98.3)

NA

  1. aRepresent the hazard ratio for death
  2. bIndicate the date for censorship of patients on the date the patient was last known to be alive
  3. NA indicate that there is no available events
  4. NE represent that the value could not be estimated